Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The observations are procedural in nature
He is Proficient in overseeing and leading teams for running successful business operations
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
The facility has been set up to manufacture tuberculosis testing cartridges
Proposed combination enhances Pfizer’s position as a leading company in oncology
Time to combine innovation, access and technology to deliver positive patient outcomes
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Subscribe To Our Newsletter & Stay Updated